Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| 1 |
NVIDIA
NVDA
|
$962M |
| 2 |
Cisco
CSCO
|
$202M |
| 3 |
Amazon
AMZN
|
$165M |
| 4 |
Johnson & Johnson
JNJ
|
$153M |
| 5 |
Pinduoduo
PDD
|
$131M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
$468M |
| 2 |
Merck
MRK
|
$306M |
| 3 |
ATVI
Activision Blizzard Inc.
ATVI
|
$305M |
| 4 |
TWNK
Hostess Brands, Inc. Class A Common Stock
TWNK
|
$299M |
| 5 |
TRTN
Triton International Limited
TRTN
|
$282M |
Sector Composition
| 1 | Technology | 18.21% |
| 2 | Financials | 17.12% |
| 3 | Industrials | 13% |
| 4 | Consumer Discretionary | 11.26% |
| 5 | Healthcare | 10.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3201
Aclaris Therapeutics
ACRS
$224M
| $197K | ﹤0.01% |
187,553
-74,180
| -28% | -$77.9K |
|
3202
Synchronoss Technologies
SNCR
$65.2M
| $196K | ﹤0.01% |
31,552
+4,452
| +16% | +$27.7K |
|
3203
NCS Multistage Holdings
NCSM
$108M
| $195K | ﹤0.01% |
+11,343
| New | +$195K |
|
3204
GCM Grosvenor
GCMG
$677M
| $191K | ﹤0.01% |
21,332
-34,540
| -62% | -$309K |
|
3205
Pixelworks
PXLW
$43.4M
| $185K | ﹤0.01% |
11,751
-907
| -7% | -$14.3K |
|
3206
Pyxis Oncology
PYXS
$99.8M
| $183K | ﹤0.01% |
101,810
-51,961
| -34% | -$93.5K |
|
3207
NetSol Technologies
NTWK
$47.1M
| $181K | ﹤0.01% |
84,378
-9,673
| -10% | -$20.8K |
|
3208
Bionano Genomics
BNGO
$17M
| $180K | ﹤0.01% |
1,589
-3,567
| -69% | -$405K |
|
|
THRX
3209
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
| $179K | ﹤0.01% |
44,145
-2,008
| -4% | -$8.13K |
|
3210
Groupon
GRPN
$942M
| $177K | ﹤0.01% |
13,803
| – | – |
|
3211
Humacyte
HUMA
$231M
| $177K | ﹤0.01% |
62,237
| – | – |
|
|
EXTO
3212
DELISTED
Almacenes Exito S.A. American Depositary Share, each representing eight (8) Common Shares
EXTO
| $175K | ﹤0.01% |
24,469
-26,239
| -52% | -$188K |
|
3213
Paysign
PAYS
$285M
| $174K | ﹤0.01% |
62,131
-12,736
| -17% | -$35.7K |
|
|
ICAD
3214
DELISTED
iCAD Inc
ICAD
| $173K | ﹤0.01% |
97,860
-15,625
| -14% | -$27.6K |
|
3215
Home Federal Bancorp
HFBL
$42.2M
| $170K | ﹤0.01% |
11,496
| – | – |
|
3216
Grupo Aval
AVAL
$3.92B
| $170K | ﹤0.01% |
69,910
-2,356
| -3% | -$5.73K |
|
|
VTNR
3217
DELISTED
Vertex Energy, Inc
VTNR
| $169K | ﹤0.01% |
49,935
+39,747
| +390% | +$135K |
|
3218
Marchex
MCHX
$89.7M
| $169K | ﹤0.01% |
124,217
-20,037
| -14% | -$27.3K |
|
|
IMMP
3219
Immutep
IMMP
$238M
| $168K | ﹤0.01% |
70,005
| – | – |
|
3220
Xponential Fitness
XPOF
$302M
| $164K | ﹤0.01% |
12,750
-36,782
| -74% | -$474K |
|
|
SILK
3221
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $164K | ﹤0.01% |
13,384
| – | – |
|
3222
Bioventus
BVS
$475M
| $163K | ﹤0.01% |
30,856
+10,978
| +55% | +$57.9K |
|
3223
Wheels Up
UP
$1.73B
| $162K | ﹤0.01% |
47,217
-4,266
| -8% | -$14.6K |
|
3224
Sensus Healthcare
SRTS
$52.3M
| $161K | ﹤0.01% |
68,092
+8,701
| +15% | +$20.5K |
|
|
ME
3225
DELISTED
23andMe Holding Co. Class A Common Stock
ME
| $159K | ﹤0.01% |
8,705
| – | – |
|